<thead id="kqoxr"></thead>
<blockquote id="kqoxr"></blockquote>
<legend id="kqoxr"><li id="kqoxr"></li></legend>
    1. <sub id="kqoxr"></sub>
      1. <blockquote id="kqoxr"><i id="kqoxr"><noscript id="kqoxr"></noscript></i></blockquote>
        <pre id="kqoxr"></pre>

        91午夜福利在线观看精品,亚洲综合色婷婷中文字幕,亚洲日本欧洲二区精品,竹菊影视欧美日韩一区二区三区四区五区,亚洲色在线V中文字幕,国产精品毛片av999999,精品视频不卡免费观看,亚洲全乱码精品一区二区

        考研英語閱讀模擬練習(xí)題

        時間:2024-05-27 20:45:56 學(xué)人智庫

        考研英語閱讀模擬練習(xí)題

          考研英語閱讀模擬練習(xí)題一:

        考研英語閱讀模擬練習(xí)題

          When Ellen M. Roche, 24, volunteered for the asthma experiment, she didn't expect to benefit from it——except for the $365 she'd be paid. Unlike clinical trials, in which most patients hope that an experimental therapy will help them, this study was designed just to answer a basic question: how does the way a normal lung reacts to irritants shed light on how an asthmatic lung responds? To find out, scientists led by Dr. Alkis Togias of Johns Hopkins University had Roche and other healthy volunteers inhale a drug called hexamethonium. Almost immediately Roche began to cough and feel short of breath. Within weeks her lungs failed and her kidneys shut down. On June 2 Roche died——a death made more tragic by the possibility that it was preventable. Last week the federal Office for Human Research Protections (OHRP) ruled that Hopkins's system for protecting human subjects is so flawed that virtually all its U.S.-supported research had to stop.

          The worst part is that Hopkins, one of the nation's premier medical institutions, is not alone. Two years ago the inspector general of the Department of Health and Human Services warned that the system safeguarding human subjects is in danger of a meltdown. The boards that review proposed studies are overburdened, understaffed and shot through with conflicts of interest. Oversight is so porous that no one knows how many people volunteer to be human guinea pigs (21 million a year is an educated guess), how many are hurt or how many die. “Thousands of deaths are never reported, and adverse events in the tens of thousands are not reported,” says Adil Shamoo, a member of the National Human Research Protections Advisory Committee and professor at the University of Maryland. Greg Koski, head of OHRP, has called the clinical-trials system “dysfunctional.”

          The OHRP findings on Hopkins are nothing short of devastating. After a three-day inspection last week, OHRP concluded that the Hopkins scientists failed to get information on the link between hexamethonium and lung toxicity, even though data were available via “routine” Internet searches and in textbooks. The drug is not approved for use in humans; the hexa-methonium Togias used was labeled [F]OR LABORATORY USE ONLY. The review board, OHRP charges, never asked for data on the safety of inhaled hexamethonium in people. The consent form that Roche signed states nowhere that hexamethonium is not approved by the FDA (the form describes it as a “medication”) and didn't warn about possible lung toxicity.

          Hopkins itself concluded that the review board did not do all it could to protect the volunteers, and suspended all 10 of Togias's studies. Still, the university——whose $301 million in federal grants for 2,000 human studies made it the largest recipient of government research money last year——is seething. “Hopkins has had over 100 years of doing clinical trials,” says Dr. Edward Miller, CEO of Johns Hopkins Medicine. “We have had one death in all of those years. We would have done anything in the world to prevent that death, but [suspending the studies] seems out of proportion.” Hopkins calls the shutdown of its experiments “unwarranted, unnecessary, paralyzing and precipitous.” OHRP is letting trials continue “where it is in the best interests” of subjects. The rest of the studies can resume once Hopkins submits a plan to restructure its system for protecting research subjects. How quickly that happens, says a government spokesman, depends on Hopkins.

          注(1):本文選自Newsweek; 7/30/2001, p36;

          注(2):本文習(xí)題命題模仿對象2005年真題Text 1;

          1. In the opening paragraph, the author introduces his topic by

          [A]explaining a phenomenon

          [B]justifying an assumption

          [C]stating an incident

          [D]making a comparison

          2. The statement “The OHRP findings on Hopkins are nothing short of devastating.”(Line 1, Paragraph 3) implies that

          [A]The OHRP findings on Hopkins are much too impressive.

          [B]The OHRP findings on Hopkins are much too shocking.

          [C]The OHRP findings on Hopkins are much too convincing.

          [D]The OHRP findings on Hopkins are much too striking.

          3. The main reasons for Roche‘s death are as following, except that _______.

          [A]the protecting system hasn‘t been set up

          [B]the review board has neglected their duty

          [C]the research team was not responsible enough for its volunteers

          [D]the possibility of lung toxicity was overlooked

          4. The OHRP has found that

          [A]Hopkins has loose control over the experiment.

          [B]the volunteers knew nothing about the experiment.

          [C]there is something wrong with every aspect of the experiment.

          [D]there exist many hidden troubles in human subjects safeguarding system.

          5. What can we infer from the last paragraph?

          [A]Hopkins had no fault in this accident.

          [B]Hopkins seemed not to quite agree with The OHRP

          [C]Togias's studies shouldn‘t be suspended.

          [D]Hopkins wanted to begin their experiments as soon as possible.

          答案:CBACB

        【考研英語閱讀模擬練習(xí)題】相關(guān)文章:

        考研英語閱讀模擬練習(xí)題(2)07-05

        考研英語閱讀理解強(qiáng)化練習(xí)題10-14

        考研英語閱讀理解鞏固練習(xí)題09-07

        考研英語閱讀理解精讀練習(xí)題07-03

        考研英語閱讀理解沖刺練習(xí)題07-11

        考研英語備考閱讀理解練習(xí)題08-07

        考研英語閱讀理解模擬題及解析(2)09-29

        考研英語閱讀理解模擬題及解析(3)10-18

        英語四級閱讀模擬練習(xí)題06-17

        考研英語完型填空模擬練習(xí)題及答案(2)08-30

        主站蜘蛛池模板: 国内精品一区二区不卡| 全部av―极品视觉盛宴| 俺去鲁婷婷六月色综合| 精品久久久久久无码免费 | 中文字幕无码不卡免费视频| 色偷偷成人一区二区三区| 色欲人妻综合网| 精品一区二区视频在线观看| 99在线精品国自产拍中文字幕| av中文天堂| 四虎成人精品无码| 日本一区二区三区精品AⅤ| 国产福利萌白酱在线观看视频 | 超碰国产精品久久国产精品99| 熟女亚洲综合精品伊人久久| 87福利影院| 最新av在线| 探花无码| 国产欧美VA天堂在线观看视频| 超碰成人精品一区二区三| 国产免费无码一区二区三区| 毛片av中文字幕一区二区| 亚洲中文字幕在线观看| 国产精品呻吟一区二区三区| 亚洲精品字幕| 91在线视频观看| 日韩中文字幕在线六区| 国产资源精品中文字幕| 国产精品999999| 精品视频九九| 亚洲午夜无码久久yy6080| 99RE8这里有精品热视频 | 天堂网中文www在线观看| 性欧美vr高清极品| 日本中文字幕在线| 色综合天堂| 亚洲不卡av中文在线| 99精品久久久中文字幕| 欧美a视频在线| 人人爽亚洲aⅴ人人爽av人人片| 国产精品极品自拍视频|